Abstract
Nuclear genome instability is known to play an important role in the origin of some human cancers. However, eukaryotic cells also have cytoplasmic genomes that are compartimentalised in the mitochondria. Mitochondria (mt) are essential for the regulation of several aspects of cell biology such as energy production, maintenance of redox status, molecular metabolism, calcium signalling and apoptosis. Oxidative stress causes significant mtDNA damage, which is thought to increase the risk of a growing number of degenerative diseases. MtDNA is highly suscepectable to mutations and contains fewer repair mechanisms than nuclear DNA, thus it may contribute to aging and be associated with the initial stages of carcinogenesis. Mitochondrial dysfunction might explain the dose-limiting toxicity of various therapeutic agents such as the nucleoside analogues used to combat HIV and hepatitis B viruses. The mitochondrial genome may represent a potential target for the development of cancer therapy. The role of mt-genomes in human diseases and in particular, in malignancy is still not fully understood. In this review, we focus on mitochondrial genome aberrations such as point mutations, instability of mono- or dinucleotide repeat, long deletions and change of the mtDNA copy number. The potential role played by mitochondria and mtDNA aberrations in malignancy, and the potential clinical use of the mtDNA markers are discussed.
Keywords: Mitochondrial Genome, dinucleotide, malignancy, mtDNA
Current Genomics
Title: Emerging Concepts in the Analysis of Mitochondrial Genome Instability
Volume: 5 Issue: 4
Author(s): Raphael Saffroy, Franck Chiappini, Brigitte Debuire and Antoinette Lemoine
Affiliation:
Keywords: Mitochondrial Genome, dinucleotide, malignancy, mtDNA
Abstract: Nuclear genome instability is known to play an important role in the origin of some human cancers. However, eukaryotic cells also have cytoplasmic genomes that are compartimentalised in the mitochondria. Mitochondria (mt) are essential for the regulation of several aspects of cell biology such as energy production, maintenance of redox status, molecular metabolism, calcium signalling and apoptosis. Oxidative stress causes significant mtDNA damage, which is thought to increase the risk of a growing number of degenerative diseases. MtDNA is highly suscepectable to mutations and contains fewer repair mechanisms than nuclear DNA, thus it may contribute to aging and be associated with the initial stages of carcinogenesis. Mitochondrial dysfunction might explain the dose-limiting toxicity of various therapeutic agents such as the nucleoside analogues used to combat HIV and hepatitis B viruses. The mitochondrial genome may represent a potential target for the development of cancer therapy. The role of mt-genomes in human diseases and in particular, in malignancy is still not fully understood. In this review, we focus on mitochondrial genome aberrations such as point mutations, instability of mono- or dinucleotide repeat, long deletions and change of the mtDNA copy number. The potential role played by mitochondria and mtDNA aberrations in malignancy, and the potential clinical use of the mtDNA markers are discussed.
Export Options
About this article
Cite this article as:
Saffroy Raphael, Chiappini Franck, Debuire Brigitte and Lemoine Antoinette, Emerging Concepts in the Analysis of Mitochondrial Genome Instability, Current Genomics 2004; 5 (4) . https://dx.doi.org/10.2174/1389202043349228
DOI https://dx.doi.org/10.2174/1389202043349228 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cardiovascular Disease Risk Among the Poor and Homeless – What We Know So Far
Current Cardiology Reviews Recent Developments on Endothelin Antagonists as Immunomodulatory Drugs - from Infection to Transplantation Medicine
Recent Patents on Cardiovascular Drug Discovery 20-Hydroxyeicosatetraenoic Acid is a Potential Therapeutic Target in Cardiovascular Diseases
Current Drug Metabolism Dipeptidyl Peptidase IV Inhibitors: A New Paradigm in Type 2 Diabetes Treatment
Current Drug Targets Nitric Oxide and Protection against Cardiac Ischemia
Current Pharmaceutical Design TakoTsubo Cardiomyopathy A Short Review
Current Cardiology Reviews New Analytical Tools for Studying Autoimmune Diseases
Current Pharmaceutical Design Reactive Oxygen Species and Antioxidants in the Pathophysiology of Cardiovascular Disease: Does the Actual Knowledge Justify a Clinical Approach?
Current Vascular Pharmacology Cellular Cardiomyoplasty – Challenges of a New Era
Current Tissue Engineering (Discontinued) Expression and Function of MicroRNAs in Enamel Development
Current Stem Cell Research & Therapy The Importance of Lost Minerals in Heart Failure
Cardiovascular & Hematological Agents in Medicinal Chemistry Altered Prolylcarboxypeptidase Expression and Function in Response to Different Risk Factors of Diabetes
Cardiovascular & Hematological Agents in Medicinal Chemistry Statins and Cardiovascular Diseases: From Cholesterol Lowering to Pleiotropy
Current Pharmaceutical Design Differentiation of Mesenchymal Stem Cells from Humans and Animals into Insulin-producing Cells: An Overview <i>In Vitro</i> Induction Forms
Current Stem Cell Research & Therapy Early Occurrence Cases of Diabetes Mellitus: Clinical Picture in Two Major Tertiary Care Hospitals in India
Current Diabetes Reviews Melatonin Alleviates Pyroptosis of Retinal Neurons Following Acute Intraocular Hypertension
CNS & Neurological Disorders - Drug Targets CA125: An Increasingly Promising Biomarker of Heart Failure
Current Pharmaceutical Design Resurgence of Herbal Antihypertensives in Management of Hypertension
Current Hypertension Reviews Editorial: Cocaine and Cerebral Small Vessel: Is it a Negative Factor for Intravenous Thrombolysis?
Current Vascular Pharmacology The Impact of Opioids on Cardiac Electrophysiology
Current Cardiology Reviews